Virological response, HIV-1 drug resistance mutations and genetic diversity among patients on first-line antiretroviral therapy in N’Djamena, Chad: findings from a cross-sectional study

Virological response, HIV-1 drug resistance mutations and genetic diversity among patients on first-line antiretroviral therapy in N’Djamena, Chad: findings from a cross-sectional study

Abstract Background The national antiretroviral therapy in the Republic of Chad provides free of charge antiretroviral regimens and therapeutic monitoring for patients receiving antiretroviral therapy nationwide. For a successful programmatic uptake, these efforts merit to be supported by thorough a...

Full description

Bibliographic Details
Main Authors: Chatté Adawaye, Joseph Fokam, Erick Kamangu, Hamit Mahamat Alio, Aoudalkarim Moussa Chahad, Fabrice Susin, Ali Mahamat Moussa, Tchombou Hig-Zounet Bertin, Abdelsalam Tidjani, Dolores Vaira, Michel Moutschen
Format: Article
Language:English
Published: BMC 2017-11-01
Series:BMC Research Notes
Subjects:
First-line antiretroviral therapy
Virological response
Drug resistance
HIV-1 subtypes
Adults
Chad
Online Access:http://link.springer.com/article/10.1186/s13104-017-2893-1

Internet

http://link.springer.com/article/10.1186/s13104-017-2893-1

Similar Items